In-hospital mortality of elderly patients with acute myocardial infarction: Data from the MITRA (Maximal Individual Therapy in Acute Myocardial Infarction) registry

被引:34
作者
Haase, KK [1 ]
Schiele, R [1 ]
Wagner, S [1 ]
Fischer, F [1 ]
Burczyk, U [1 ]
Zahn, R [1 ]
Schuster, S [1 ]
Senges, J [1 ]
机构
[1] Heart Ctr Ludwigshafen, D-67063 Ludwigshafen, Germany
关键词
acute myocardial infarction; early therapy; age;
D O I
10.1002/clc.4960231109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Advanced age remains one of the principal determinants of mortality in patients with acute myocardial infarction (AMI). Hypothesis: The aim of this study was to determine the in-hospital outcome of elderly (> 75 years) patients with AMI who were admitted to hospitals participating in the national MITRA (Maximal Individual Therapy in Acute Myocardial Infarction) registry. Methods: MITRA is a prospective, observational German multicenter registry investigating current treatment modalities for patients presenting with AMI. All patients with AMI admitted within 96 h of onset of symptoms were included in the MITRA registry. MITPA was started in June 1994 and ended in January 1997. This registry comprises 6,067 consecutive patients with a mean age of 65 +/- 12 years, of whom 1,430 (17%) were aged > 75 years. Patients were compared with respect to patient characteristics, prehospital delays, early treatment strategies, and clinical outcome. Results: In the elderly patient population, the prehospital delay was 210 min, which was significantly longer than that for younger patients (155 min, p = 0.001). Although the incidence of potential contraindications for the initiation of thrombolysis was almost equally distributed between the two age groups (8.7 vs. 8.2%, p = NS), elderly patients (> 75 years) received reperfusion therapy less frequently (35.9 vs. 64.6%) than younger patients. Mortality increased with advanced age and was 26.4% for all patients aged > 75 years. If reperfusion therapy was initiated, in-hospital mortality was 21.8 versus 28.9% in patients aged > 75 years (p = 0.001) and 29.4 versus 38.5% in patients aged > 85 years (p = 0.001). Conclusion: In this registry, elderly patients with AMI had a much higher in-hospital mortality than that expected from randomized trials. In MITRA, the mortality reduction with reperfusion therapy was found to be highest in the very elderly patient population.
引用
收藏
页码:831 / 836
页数:6
相关论文
共 19 条
[1]  
[Anonymous], 1990, LANCET, V336, P65
[2]  
[Anonymous], 1988, LANCET, V2, P349
[3]  
[Anonymous], 1989, NEW ENGL J MED, V320, P618
[4]  
[Anonymous], 1986, LANCET, V2, P57
[5]   Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour [J].
Boersma, E ;
Maas, ACP ;
Deckers, JW ;
Simoons, ML .
LANCET, 1996, 348 (9030) :771-775
[6]  
*GRUPP IT STUD STE, 1987, LANCET, P871
[7]   VARIATION IN THE USE OF CARDIAC PROCEDURES AFTER ACUTE MYOCARDIAL-INFARCTION [J].
GUADAGNOLI, E ;
HAUPTMAN, PJ ;
AYANIAN, JZ ;
PASHOS, CL ;
MCNEIL, BJ ;
CLEARY, PD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (09) :573-578
[8]  
HJALMARSON A, 1981, LANCET, V2, P823
[9]  
HUNT D, 1992, LANCET, V339, P753
[10]   IMPACT OF CLINICAL-TRIALS ON CLINICAL-PRACTICE - EXAMPLE OF THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION [J].
KETLEY, D ;
WOODS, KL .
LANCET, 1993, 342 (8876) :891-894